• Medical_Professionals
• Medical_students
• Nurses

Immuno-Oncology 360° provides the most up-to-date research, data and progress to help IO stakeholders:

Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy

Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof​

Receive the latest pre-clinical, translational and clinical data from academic and industry

Identify and gain a greater understanding of what assets are available for potential combinations  

Create and prioritize strategies targeted toward specific tumor types​

Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned

Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next

Hear reports on industry trends from Endpoint News and BioCentury Innovations and a progress update on the Cancer Moonshot

Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more

Obtain coverage on a wide range of emerging technologies

Please contact us at service@tcfllc.org if you have any questions. Thank you and we look forward to seeing you in February.

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

The Roosevelt Hotel New York

45 East 45th Street & Madison Avenue

New York, NY 10017

212-661-9600

www.theroosevelthotel.com

Please call (212) 661-9600 or email reservations@rooseveltnyc.com to make your reservation. We recommend you book your room as soon as possible.

Submission Info

Sponsorships are available for organizations that provide the following services or technologies:

CROs/Clinical Trial Design

Diagnostic Testing

Molecular Diagnostics

Biomarker Software

Tumor Biology

Assay Development

Bi-Specific Antibodies

Next Gen Sequencing

mRNA/DNA Nucleic Acid Processing

RNA Sequencing

Cell Analysis/Manufacturing Platforms

Monoclonal Antibody(MaB) Engineering

Liquid Biopsies

Immune Monitoring

Cancer Genetics

Imaging Services

Flow Cytometry

Data Analysis/Analytics

Laboratory Services

Consultants

Speaking Opportunities

The conference presents and opportunity for your company to present a case study, take part in a panel discussion or present your company in a spotlight format.

io360-sponsor-stagepic

Exhibit

Showcase your company in front of this prestigious audience.

Interact with attendees at your booth during Registration, Lunch, Morning and Afternoon breaks, as well as the event reception

Showcase your service or technology with signs front and center

Opportunity to Exhibit & Sponsor are still available

– Download Floorplan – 

Benefits of being a part of the event

Receive passes to attend

Your logo with hyperlink to your website and a company description will be on the conference website

Have on-site branding in the materials and brochure handed out to all attendees

Your logo on event signs

Customized marketing including a discount code for attendance to give to your clients or prospects

Receive the confidential attendee list

Handshakes with the people of your choice will be facilitated

Quick-fire & Biotechnology Showcase

Novel biotechnology companies that are developing immunotherapy assets have the opportunity to showcase their data in front of large pharma and investors who are seeking new innovative sources to contribute to their pipelines to advance the treatment of cancer. Service providers have an opportunity to showcase how they are able to collaborate and partner with BioPahrm companies. The showcase package includes branding and networking benefits as follows:

One all-access pass to attend the event.

Logo and fifty word description on the conference website (with hyperlink to your site) and in the conference brochure.

25% discount to your clients or anyone you want to invite to the event through a custom code that we will track for you.

Logo on signage at the event.

Literature on a shared table

To request a showcase registration form, contact Meredith Sands at Meredith@tcfllc.org or 646-350-2586.

2018 Executive Sponsors

Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. Learn more at www.adaptivebiotech.com

Imaging Endpoints (IE) is a mission driven research and imaging CRO with offices in Scottsdale, Arizona and Waltham, Massachusetts.  We specialize in providing the industry’s leading imaging expertise and most advanced technologies coupled with exquisite services.  Our experience extends from translational to phase 3 trials and every step in-between. Our organization is unique in that it is owned by a team of over 40 in-house radiologists and nuclear medicine physicians that specialize in advanced imaging technologies. Our comprehensive services span all aspects of trial planning and conduct, including protocol development, site qualification and standardization, real-time image receipt/QC and reads, data management, regulatory compliance and preparation for meetings/submissions to regulatory authorities. Our Rapid Detection and Assessment of Response program (RaDAR) is designed to accelerate product development by integrating the most advanced imaging technologies into clinical trials. At Imaging Endpoints, our capabilities go above and beyond the typical imaging core lab offering. Learn more at www.imagingendpoints.com

2018 Associate Sponsors

Defined Health is a leading biopharmaceutical asset development strategy consultancy with 25+ years of experience.  Our consultants hold advanced degrees in science, medicine and business, and have industry experience in business development, commercial evaluation, finance, licensing, drug discovery and R&D. Our clients include top global pharma, large cap biotech, specialty pharma and hundreds of pre-commercial biotech and platform technology companies. Our work encompasses asset evaluation, early commercial strategy, indication prioritization and sequencing, life-cycle management and search and evaluation. Learn more at www.definedhealth.com.

2018 Exhibitors

Axio Research offers a comprehensive range of statistical genetics and genomics services to clients undertaking drug discovery and companion diagnostics development. Merging deep experience in statistical genetics, bioinformatics, and biostatistics with clinical understanding, Axio applies leading-edge statistical and computational methods to support and expedite genomic discovery. Reach us at: info@AxioResearch.com. Learn more about us at www.axioresearch.com.

Caprion is a specialty CRO providing laboratory services to pharmaceutical/biotechnology companies with GCP/GLP/GCLP capabilities. Caprion’s ImmuneCarta® Division, offers multi-parametric flow cytometry, cytokine testing, and ELISpot for analyses of innate and adaptive immune responses. Caprion’s  ProteoCarta™ Division leverages its expertise in mass spectrometry for protein analysis in support of biomarkers development. Learn more about us at www.caprion.com

Cytel is shaping the future of drug development. As the world’s largest Biometrics CRO, we improve our customers’ chances of success through expert trial design, efficient operational implementation and reliable clinical data management. Learn about our clinical research services capabilities, in addition to the Cytel line of statistical and operations-support software at www.cytel.com.

Intrinsic Imaging is an FDA audited, ISO 9001, ISO 13485 and ISO 22301 certified and GAMP® 5 compliant medical imaging core lab. At Intrinsic, we have the team, the technology and the therapeutic expertise to manage your entire medical imaging trial providing comprehensive services in support of Phase I-IV Clinical Trials. For more information, please visit www.intrinsicimaging.com

KIYATEC prioritizes accurate ex vivo prediction of patients’ drug response, focused primarily on data correlation to human clinical outcomes. Our drug response profiling services utilize phenotypic 3D cell-based models for predicting patient response. KIYATEC’s 3D perfusion tissue microenvironments are particularly useful for investigating the efficacy of both immuno-oncology therapies and chemotherapeutics. For more information, please visit us at www.kiyatec.com

Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery. Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation, it can be used to predict response of an indication to a specific drug (or drug combination), or to better understand MOA of a given compound. Founded in 2010, Mitra is headquartered in Boston and maintains a significant research and laboratory presence in Bangalore, India. Visit us at www.mitrabiotech.com

NeoGenomics is a premier cancer diagnostics and pharma services company. We serve the needs of oncologists, pathologists, pharmaceutical companies, academic centers, and other healthcare professionals with innovative diagnostic, prognostic and predictive testing. We provide anatomic pathology, flow cytometry, FISH, cytogenetics, molecular, and genomic technologies. Our experience with companion and complementary diagnostics is unparalleled and we are the lab of choice for the pharma industry for clinical trial lab services. Visit www.neogenomics.com.

Personalis, Inc is a leading precision medicine company focused on advanced NGS-based clinical diagnostic, clinical trial and research services for cancer and inherited genetic disease. Personalis also provides DNA sequencing and data analysis of human genomes. Our ACE Exome and Transcriptome technology is designed to obtain the most comprehensive and accurate tumor molecular profile for immuno-oncology applications. The company’s clinical laboratory is GCP compliant, CLIA licensed and CAP accredited. Visit www.personalis.com.

IO360° Team , The Conference Forum

Phone: 646-350-2580

Email: service@tcfllc.org